FindTrial
Sign In

Platelet to albumin ratio to predict diabetic nephropathy among T2DM

The platelet to albumin ratio a predictive marker in assessment of diabetic nephropathy among type 2 diabetes mellitus - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085507
Enrollment
120
Registered
2025-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications

Interventions

Intervention1: Nil: Nil

Sponsors

Komal Dhamanekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Case: Patients with T2DM Control: Non diabetic patients

Exclusion criteria

Exclusion criteria: Acute or chronic infections Auto immune diseases Tumors Heamatological Diseases Liver insufficiency

Design outcomes

Primary

MeasureTime frame
Role of Platelet to Albumin ratio in Diabetic Nephropathy among T2DMTimepoint: 24 Weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Reshma Channashetti

KLEs Jawaharlal Nehru Medical College Belagavi

dcrashmi@yahoo.com9538635336

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026